Brought to you by 
Angiotech Pharmaceuticals buys device company AMI Holdings
07 Feb 2006
Executive Summary
In an effort to transform itself from an R&D to a products company, Canadian biotech Angiotech Pharmaceuticals (drug-eluting medical devices and biomaterials) will purchase AMI Holdings Inc., a privately held US medical device maker.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Angiotech Pharmaceuticals buys device company AMI Holdings
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice